Latest Observability News

Page 81 of 85
Torque Metals delivers standout drilling results at its Paris Gold Project, confirming high-grade gold zones beyond existing resources, while bolstering its portfolio with new gold and lithium tenements and a successful $1M share placement.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Percheron Therapeutics has terminated its phase IIb avicursen trial for Duchenne muscular dystrophy after failing to meet efficacy endpoints, while securing $14.85 million in fresh capital to explore new therapeutic opportunities.
Ada Torres
Ada Torres
31 Jan 2025
Apollo Minerals reports exceptional drilling results at its Salanie Gold Project in Gabon, revealing high-grade gold mineralisation and securing $1.25 million through a recent entitlement offer.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Avecho Biotechnology progresses its Phase III clinical trial for a TPM®-enhanced CBD insomnia capsule, expands patient recruitment, and completes a major manufacturing campaign for its U.S. partner Ashland.
Ada Torres
Ada Torres
30 Jan 2025
RLG Ltd has successfully raised $900,000 through a two-tranche placement to fund the development of its food and health products and expand global sales channels. The second tranche, involving options issuance, awaits shareholder approval.
Victor Sage
Victor Sage
30 Jan 2025
88 Energy Limited announces a maiden internal Prospective Resource estimate of 283 million barrels of oil for its Canning Prospect at Project Leonis, Alaska, with plans to drill the Tiri-1 exploration well targeting multiple reservoirs in 2026.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Alterity Therapeutics has announced encouraging Phase 2 trial results for ATH434, showing significant slowing of disease progression in multiple system atrophy (MSA) patients and a strong safety profile. These findings mark a potential breakthrough in treating a disease with no approved therapies.
Ada Torres
Ada Torres
30 Jan 2025
Argenica Therapeutics has received a positive safety review from its independent DSMB for the Phase 2 trial of ARG-007 in acute ischaemic stroke patients, with dosing now 86% complete and full recruitment expected by early Q2 2025.
Ada Torres
Ada Torres
30 Jan 2025
Southern Cross Gold Consolidated has reported exceptional high-grade gold intersections from deep drilling at its Christina prospect, confirming robust mineralization extending 350 metres below previous hits and expanding the Sunday Creek project's footprint.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Nickel Industries reveals a substantial Exploration Target of 350 to 700 million dry metric tonnes at 0.9% to 1.1% nickel for its Sampala Project, complementing an existing 187 million dmt resource. The company has initiated mine development and haul road construction, positioning itself for a secure nickel supply chain.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Barton Gold has confirmed significant high-grade silver alongside gold in its Tolmer gold system at the Tarcoola Project, prompting a new drilling campaign to explore the promising mineralisation further.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Heavy Rare Earths Limited (ASX:HRE) advanced its uranium exploration footprint in South Australia with a key asset acquisition and bolstered its balance sheet through a $2.46 million capital raise during the December 2024 quarter.
Maxwell Dee
Maxwell Dee
30 Jan 2025